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Abstract
Alcoholic liver disease (ALD) is a complex chronic disease and is associated with a spectrum of liver injury ranging 
from steatosis and steatohepatitis to fibrosis and cirrhosis. Since effective therapies for ALD are still limited, Chinese 
herbal medicine is thought to be an important and alternative approach. This review focuses on the current scientific 
evidence of ALD by ten Chinese Materia Medica (中藥 zhōng yào), including Salviae Miltiorrhizae Radix (丹參 dān 
shēn), Notoginseng Radix (三七 sān qī), Lycii Fructus (枸杞子 gǒu qǐ zǐ), Cnidii Fructus (蛇床子 shé chuáng zǐ), 
Gentianae Radix (龍膽 lóng dǎn), Puerariae Radix (葛根 gé gēn), Puerariae Flos (葛花 gé huā), Magnoliae Officinalis 
Cortex (厚朴 hòu pò), Platycodonis Radix (桔梗 jié gěng), and Trigonellae Semen (胡蘆巴 hú lú bā). Potential 
mechanisms of these herbal medicines in ALD are involved in amelioration of enhanced inflammation, reduction of 
hepatic oxidative stress and lipogenesis, and enhancement of intestinal permeability in alcohol-induced liver injury 
models in vitro and in vivo . Accordingly, the evidenced therapeutic potential suggests that these herbs are promising 
candidates for prevention and development of new drugs for ALD in the future.
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Introduction
World Health Organization has reported that the 
harmful use of alcohol is one of the world’s leading 
health risks. Approximately 4.5% of the global burden 
of diseases and injury can be attributable to alcohol, 
which results in approximately 2.5 million deaths each 
year (World Health Organization, 2011). Chronic or 
excessive alcohol consumption is one of the major 
causes of liver disease and injury. Since the liver is the 
largest human organ and metabolizes various substances 
that can damage the body, it is important to prevent 
damage to healthy liver or repair the damaged liver from 
alcoholic liver disease (ALD) for a healthy life (Chien et 
al., 2011).
ALD is a complex chronic disease and typically 
progresses through multiple stages of alcoholic steatosis, 
hepatitis and cirrhosis to end-stage liver disease (Haber 
et al., 2003; Seth et al., 2008). The major feature of 
ALD is the enhanced inflammation in liver during 
alcohol exposure. Dysregulated cytokine metabolism 
and activity such as tumor necrosis factor (TNF-α) are 
crucial to the initiation of alcohol-induced liver injury 
(An et al., 2012). In addition, hepatic oxidative stress 
is known to play a prime role in the pathogenesis of 
ALD (Bondy, 1992). Induction of cytochrome P450 2E1 
(CYP2E1) by alcohol is also another key pathway since 
the pathological changes in early alcoholic liver injuries 
such as steatosis and steatohepatitis are associated 
This is an open access article under the CC BY-NC-ND license.
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with CYP2E1 levels (Stewart et al., 2001; Wu and 
Cederbaum, 2005). Moreover, alcohol can impair fat 
oxidation and stimulate lipogenesis by interfering with 
DNA binding and transcription-activating properties of 
peroxisome proliferator-activated receptor-α (PPARα) 
and activating sterol regulatory element-binding protein 
1 (SREBP-1) (You et al., 2002; You and Crabb, 2004). 
Understanding the mechanism underlying alcohol-
induced effects provides an array of potential candidate 
for novel new therapeutic targets to reverse ALD.
In traditional Chinese medicine (TCM), liver disease 
such as fibrosis is perceived to be caused by poor blood 
circulation, toxin accumulation, and energy deficiency. 
Accordingly, Chinese medicine used therapy to treat 
liver injury is mainly based on increasing blood 
circulation, eliminating toxins, resolving stasis, and 
enhancing body immunity (Feng et al., 2009). However, 
perspectives on evidence-based medicine nowadays are 
encouraging medical practitioners to be guided in their 
practice by available scientific evidence in terms of 
efficacy and safety for individual therapies (Fogden and 
Neuberger, 2003). In the present review, an attempt is 
made to survey and comprehensively compile the recent 
scientific evidence regarding Chinese Materia Medica 
(CMM) (中藥 zhōng yào) and ALD through PubMed 
database (http://www.ncbi.nlm.nih.gov/pubmed/). All 
CMMs shown in this review were selected due to their 
experimental evidences in vivo and/or in vitro.
Chinese herbal medicines against alcoholic 
liver disease
Salviae Miltiorrhizae Radix (丹參 dān shēn; the root 
of Salvia miltiorrhiza, Labiatae)
Salviae Miltiorrhizae Radix (SMR) has been used in 
the treatment of hypertension, coronary heart disease 
and myocardial infarction in TCM (Lei and Chiou, 
1986; Sun et al., 2005; Wang et al., 1989). Also, it has 
been used widely to treat chronic liver disease. An in 
vivo  study elucidated the protective effect of SMR 
on chronic alcoholic liver injury employing a mice 
model (Xiong et al., 2005). Administration of SMR 
(5 ml/kg bw, i.p.) could alleviate the alcohol-induced 
fatty degeneration and adiponecrosis of hepatic cells 
in Kunming mice. The protective mechanisms of SMR 
were probably due to the down-regulation of TLR-4 and 
HO-1 mRNA expressions and significant decrease of 
TLR-4 positive cell number in the animal study.
Cryptotanshinone and tanshinone IIA (Figure 1), 
diterpenes contained in SMR, were considered as 
active hepatoprotective components. In primary rat 
hepatocytes, 10 μM cryptotanshinone suppressed 
alcohol-induced lipid accumulation, and inhibited 
activation and nuclear translocation of sterol regulatory 
element-binding protein 1 (SREBP-1) and the 
consequent transactivation of the target genes involved 
in fatty acid biosynthesis (Yin et al., 2009a). On the 
other hand, 10 μM tanshinone IIA protected RAW 264.7 
cells from alcohol-induced production of superoxide 
radical, activation of NADPH oxidase, and subsequently 
death of the cells. Alcohol-induced expressions of 
CD14, iNOS, and SCD1 were completely reversed by 
tanshinone IIA. Also, tanshinone IIA effectively blocked 
alcohol-induced fat accumulation in rat hepatoma 
cells (H4IIEC3). Consequently, tanshinone IIA is the 
major active component of SMR to inhibit alcoholic 
liver disease by reducing alcohol-induced Kupffer 
cell sensitization, decreasing synthesis of reactive 
oxygen/nitrogen species and fatty acid synthesis, and 
stimulating fatty acid oxidation (Yin et al., 2008).
Notoginseng Radix (三七 sān qī; the root of Panax 
notoginseng (Burk.) F.H. Chen, Araliaceae)
Notoginseng Radix is known in TCM to improve 
blood circulation and has been used to treat angina 
pectoris due to its property to increase coronary blood 
flow. Bioactivities associated with Panax notoginseng 
include anti-inflammatory, analgesic, antitumor, 
antihypertensive, anti-atherosclerotic, antithrombotic, 
neuroprotective and hepatoprotective effects (Ng, 
2006; Pan et al., 2011). An animal study elucidated the 
hepatoprotective effects exerted by a hot water extract 
of P. notoginseng  (PNG) in alcohol-fed ICR mice (Lin et 
al., 2003). PNG (10 mg/kg bw, p.o.) prevented the rise 
in serum glutamate–oxaloacetate transaminase (sGOT, 
AST) and glutamate–pyruvate transaminase (sGPT, 
ALT), and inhibited the hepatic lipid peroxidation 
(26% inhibition rate) against chronic alcohol-induced 
hepatotoxicity.
Figure 1. Structures of cryptotanshinone and tanshinone IIA from 
Salvia miltiorrhiza
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Lycii Fructus (枸杞子 gǒu qǐ zǐ; the fruit of Lycium 
barbarum, Solanaceae)
Lycii Fructus, commercially known as goji berry, has 
historically been used in TCM to improve eyesight and 
to strengthen the liver and kidney (Lee et al., 2012). 
The bioactivity of Lycii Fructus is mainly attributed to 
its polysaccharide complex (Figure 2), which consists 
of six monosaccharides (galactose, glucose, rhamnose, 
arabinose, mannose, and xylose). A recent in vivo study 
reported that Lycium barbarum  polysaccharide (LBP) at 
a dose of 300 mg/kg bw significantly ameliorated liver 
injury by decreasing serum aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) activities 
and improving the antioxidant functions in alcohol-
fed rats (Cheng and Kong, 2011). Moreover, LBP 
prevented the progression of alcohol-induced fatty liver 
by decreasing the levels of serum triglycerides, total 
cholesterol, and low density lipoprotein cholesterol, and 
by increasing high density lipoprotein cholesterol level.
Cnidii Fructus (蛇床子 shé chuáng zǐ; the fruit of 
Cnidium monnieri (L.) Cusson, Apiaceae)
Cnidii Fructus has been used in the treatment of skin 
disease and gynecopathy in Chinese herbal medicine 
for many years (Lian, 2003). Osthole (Figure 3) is 
a coumarin isolated from Cnidii Fructus. Modern 
pharmacological studies reported that osthole prevented 
the development of hepatitis and hepatocellular 
carcinoma induced by anti-Fas antibody in mice 
(Okamoto et al., 2003; Okamoto et al., 2005). Recent 
studies showed that osthole (40 mg/kg bw, p.o.) 
dramatically decreased lipid accumulation to inhibit 
development of alcohol-induced fatty liver in Kunming 
mice (Sun et al., 2009). The potential mechanisms 
were related to reduction of hepatic oxidative stress, 
enhancement of antioxidative enzyme activity, reduction 
of lipid accumulation and peroxidation, and regulation 
the gene expressions of diacylglycerol acyltransferase 
(DGAT), 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) 
reductase and cholesterol 7α-hydroxylase (CYP7A) 
mediated by increasing the peroxisome proliferator-
activated receptor-α (PPARα) mRNA expression (Sun et 
al., 2010; Zhang et al., 2011).
Gentianae Radix (龍膽 lóng dǎn; the root of 
Gentiana manshurica Kitagawa, Gentianaceae)
Gentiana manshurica  Kitagawa is abundantly 
distributed in northeastern China and has been used 
traditionally as a folk remedy by Chinese people 
suffering from chronic liver disease (Wang et al., 
2010). A recent in vivo  study showed the protective 
effects of Gentianae Radix methanolic extract (GM) 
on acute alcohol-induced fatty liver (Lian et al., 2010). 
Treatment of GM (200 mg/kg bw) significantly reduced 
the increases in serum aspartate aminotransferase 
(AST) and alanine aminotransferase (ALT) levels, and 
the serum and hepatic triglyceride levels in ethanol-
administered C57BL/6 mice. GM was also found to 
prevent alcohol-induced hepatic steatosis and necrosis 
by suppressing the elevation of malondialdehyde 
(MDA) levels, restoring the glutathione (GSH) levels, 
and enhancing the superoxide dismutase (SOD), catalase 
(CAT), and glutathione peroxidase (GPx) activities. 
Moreover, GM efficaciously abrogated cytochrome 
P450 2E1 (CYP2E1) induction and significantly reduced 
the nuclear translocation of activating sterol regulatory 
element-binding protein 1 (SREBP-1) in alcohol-treated 
mice. In summary, GM possessed the ability to prevent 
alcohol-induced acute liver steatosis by blocking 
CYP2E1-mediated free radical scavenging effects and 
SREBP-1-regulated fatty acid synthesis.
Puerariae Radix (葛根 gé gēn; the root of Puerariae 
lobata, Leguminosae) and Puerariae Flos (葛花 gé 
huā; the flower of P. lobata)
Puerariae Radix (PR) and Puerariae Flos (PF) have 
been used in TCM to counteract problems associated 
with alcohol drinking and liver injury since ancient 
times (Keung and Vallee, 1998). The hepatoprotective 
effects of PR and PF in alcoholic liver damage have 
been experimentally demonstrated in animal studies 
Figure 2. Structure of polysaccharide from Lycium barbarum
Figure 3. Structure of osthole from Cnidium monnieri
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(Lee et al., 2001). Water extracts of PR and PF (mixed 
with the diets based on 1.2 g of raw PR or PF/kg bw/
day) were reported to normalize antioxidant enzymes, 
including significant increase of the Cu/Zn superoxide 
dismutase (SOD) and/or catalase (CAT) activities and 
decrease of the glutathione peroxidase (GPx) activity, 
to the control level in the alcohol-treated Sprague-
Dawley rats. Similarly, another animal study showed 
that PR water extract (mixed with the diets based on 1.5 
g of raw PR/kg bw/day) alleviated the adverse effect of 
alcohol ingestion in Sprague-Dawley rats by enhancing 
the lipid metabolism as well as the hepatic antioxidant 
defense system (Lee, 2004). Moreover, a recent study 
showed that the inhibitory effect of PR extract (mixed 
with alcohol based on 3 g of raw PR/kg bw/day, p.o.) on 
alcohol-induced liver damage in Wistar rats was through 
enhancement of intestinal permeability to improve 
intestinal barrier dysfunction induced by alcohol (Zhang 
et al., 2009).
Tectoridin (Figure 4) is an isoflavone glycoside 
isolated from the flower of P. lobata  and considered 
as an active component in liver protection. The 
hepatoprotective activity of tectoridin has been 
experimentally shown on tert-butyl hyperoxide-
induced hepatotoxicity in mice (Lee et al., 2005). 
Recently, it was demonstrated that tectoridin prevented 
acute alcohol-induced liver steatosis in C57BL/6 
mice (Xiong et al., 2010). Treatment of 50 mg/kg 
bwtectoridin significantly alleviated the over-production 
of thiobarbituric acid-reactive substance. Furthermore, 
tectoridin inhibited the reduction of peroxisome 
proliferator-activated receptor-α (PPARα) expression 
and its target genes, including medium-chain acyl-CoA 
dehydrogenase (MCAD), acyl-CoA oxidase (ACO) and 
cytochrome P450 4A (CYP 4A) at mRNA and enzyme 
activity levels. The possible mechanism of tectoridin 
to inhibit alcohol-induced hepatotoxicity was mainly 
by modulating the disturbance of PPARα pathway and 
ameliorating mitochondrial function.
Magnoliae Officinalis Cortex (厚朴 hòu pò; the 
stem bark of Magnolia officinalis Rehd. et Wols, 
Magnoliaceae)
Magnoliae Officinalis Cortex (MOC) is a traditional 
Chinese herbal medicine that has been used for 
treatment of gastrointestinal disorders, anxiety and 
allergic disease (Lee et al., 2011). A recent study 
showed that the ethanolic extract of MOC (50 μg/ml) 
was able to protect alcohol-induced cell death by 
decreasing the production of TNF-α, reactive oxygen 
species and superoxide anion radicals, and by inhibiting 
the activation of NADPH in RAW264.7 cells. In 
ethanol diet-fed animal model, Wistar rats treated 
with the ethanolic extract of MOC (45 mg/kg bw/day) 
completely reversed all the serum, hepatic parameters, 
and fatty liver changes by inhibiting maturation of 
activating sterol regulatory element-binding protein 1c 
(SREBP-1c) (Yin et al., 2009b).
Honokiol and magnolol (Figure 5) are isomers 
of biphenolic compounds isolated from MOC. In 
Lieber-DeCarli alcohol diet-fed Wistar rats, daily 
administration of honokiol (10 mg/kg bw) exerted 
efficacious abrogation of fat accumulation in the liver 
and completely reversed the effects on hepatotoxicity 
markers, including decreased hepatic glutathione and 
increased hepatic triglyceride and serum TNF-α. In 
addition, honokiol (10 μg/ml) reversed the production 
of lipid droplets in alcohol-treated H4IIEC3 cells. 
The investigation of mechanisms demonstrated that 
honokiol inhibited the maturation of SREBP-1c and its 
translocation to the nucleus, the binding of nSREBP-
1c to SRE or SRE-related sequences of its lipogenic 
target genes, and the expression of genes for fatty 
acid synthesis. In contrast, magnolol had no effect on 
nSREBP-1c levels (Yin et al., 2009c).
Figure 4. Structure of tectoridin from Puerariae lobata Figure 5. Structures of honokiol and magnolol from Magnolia 
officinalis
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Platycodonis Radix (桔梗 jié gěng; the root of 
Platycodon grandiflorum  A. DC, Campanulaceae)
Platycodonis Radix (PR) is used as a food additive 
and has been employed for treatment of inflammatory 
diseases and geriatric diseases such as bronchitis, 
asthma and pulmonary tuberculosis in TCM (Guo et 
al., 2007). The protective effects of PR on the liver 
have been demonstrated in rats with alcohol-induced 
hepatotoxicity. Administration of PR significantly 
prevented alcohol-induced elevation of serum and liver 
lipids by normalizing hepatic liver fatty acid binding 
protein (L-FABP) expression and cytochrome P450 2E1 
(CYP2E1) activity in alcohol-treated Sprague-Dawley 
rats (Kim et al., 2007). A recent study also reported 
that PR (both the total extract and saponin fraction) had 
protective effects against alcohol-induced damage in 
vitro and in vivo (Noh et al., 2011). The heptoprotective 
mechanism of PR is by inhibition of lipid accumulation 
and peroxidation through the enhancement of the 
antioxidant defense system such as significant decrease 
of glutamic oxalacetic transaminase, glutamic pyruvic 
transaminase, hepatic triglyceride and thiobarbituric 
acid reactive substance levels.
Saponins (Figure 6) isolated from the PR (Changkil 
saponins, CKS) were reported to be the active 
components in hepatoprotective effects. To obtain 
saponin fraction, aqueous extract of Platycodonis 
Radix was subjected to column chromatography to 
remove saccharides and amino acids (Tada et al., 
1975). In vivo studies showed that pretreatment with 
CKS (1 mg/kg bw/day for 7 days) prior to ethanol 
administration significantly prevented alcoholic liver 
injury in C57BL/6 mice by inhibiting the increases in 
serum alanine aminotransferase activity (ALT), hepatic 
TNF-α level, hepatic lipid peroxidation, and hepatic 
triglyceride level (Khanal et al., 2009a). In Lieber-
DeCarli alcohol diet-fed Sprague–Dawley rats, the 
possible hepatoprotective mechanisms of CKS treatment 
(1 mg/kg bw/day for 2 weeks) in alcohol-induced 
liver damage were done through reduction of CYP2E1 
expression, recovery of AMP-activated protein kinase-
alpha (AMPKα) phosphorylation, and an increase in 
acetyl-CoA carboxylase phosphorylation (Khanal et al., 
2009b).
Trigonellae Semen (胡蘆巴 hú lú bā; the seed of 
Trigonella foenum-graecum, Leguminosea)
Trigonel la  foenum-graecum , a lso known as 
Fenugreek, is an annual herb and has a long history 
as both a culinary and medicinal herb. In Asia, seeds 
of this herb are commonly used as a spice in food 
preparations due to the strong aroma and flavor. 
Trigonellae Semen possesses restorative and nutritive 
properties and has been used in remedies for diabetes 
and hypercholesterolemia in Indian, Arabic and 
Chinese medicine. (Khosla et al., 1995; Sharma et al., 
1990; Sharma et al., 1996). Aqueous extract (1%) of 
Trigonellae Semen (2 ml, twice daily) was reported to 
offer a significant protection against ethanol toxicity in 
Wistar rats by enhancement of the antioxidant potential 
and prevention of the enzymatic leakage and the rise in 
lipid peroxidation (Thirunavukkarasu et al., 2003).
Further studies indicated that the polyphenolic extract 
of Trigonellae Semen was considered cytoprotective 
during alcohol-induced liver damage in vitro  and in 
vivo . Treatment of 20 to 60 μg/ml Trigonellae Semen 
polyphenol extract (FPEt) prevented alcohol-induced 
toxicity and apoptosis in human Chang liver cells 
by reducing thiobarbituric acid reactive substance 
formation and decreasing the accumulation of sub-G1 
phase cells (Kaviarasan et al., 2006). Moreover, FPEt 
ameliorated the pathological liver changes induced by 
chronic alcohol feeding in Wistar rats. Administration 
of FPEt a dose of 200 mg/kg bw/day significantly 
improved lipid profile and reduced collagen content, 
aldehyde content and peroxidation (Kaviarasan et al., 
2007). Furthermore, the protective effects of FPEt in 
alcoholic fatty liver diseases may involve in reducing 
the levels of lipid peroxidation products and protein 
carbonyl content, increasing the activities of antioxidant 
enzymes, and restoring the levels of thiol groups such as 
protein and non-protein thiols (Kaviarasan et al., 2008).
Figure 6. Structure of saponin from Platycodon grandiflorum
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Conclusion
Herbal medicines have been used in China for more 
than 2,000 years. However, Chinese herbal medicines 
did not receive extensive analytical attention through 
western scientific methods until recent decades. In 
this review, ten herbal medicines traditionally used in 
Chinese Materia Medica have been experimentally 
demonstrated by modern in vitro  and in vivo  studies 
on alcohol-induced liver injury. As shown in Table 1, 
the potentially protective mechanisms of these herbs in 
alcoholic liver disease are involved in amelioration of 
enhanced inflammation, reduction of hepatic oxidative 
stress and lipogenesis, and enhancement of intestinal 
permeability. Hence, the evidenced therapeutic potential 
of these herbs suggests that Chinese herbal medicines 
may be good resources for prevention and development 
of new drugs for ALD in the future.
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Table 1. Hepatoprotective effect of Chinese herbal medicine against alcoholic liver disease
Chinese Materia Medica Experimental model Treatment Proposed mechanism (reference)
Salviae Miltiorrhizae Radix 
丹參 (dān shēn)
Hepatic cells in 
Kunming mice
SMR extract 
(5 ml/kg bw, i.p.)
Decreased TLR-4 & HO-1 levels; decreased TLR-4 
positive cell number
 (Xiong et al., 2005)
Primary rat hepatocytes Cryptotanshinone 
(10 μM)
Inhibited activation and nuclear translocation of 
SREBP-1 
(Yin et al., 2009a)
RAW 264.7 cells Tanshinone IIA 
(10 μM)
Reversed of CD14, iNOS, & SCD1 
(Yin et al., 2008)
Rat hepatoma cells 
(H4IIEC3)
Tanshinone IIA 
(10 μM)
Reduced alcohol-induced Kupffer cell sensitization; 
decreased synthesis of reactive oxygen/nitrogen 
species & fatty acid synthesis; stimulated fatty acid 
oxidation 
(Yin et al., 2008)
Notoginseng Radix 
三七 (sān qī)
ICR Mice PNG 
(10 mg/kg bw, p.o.)
Increased sGOT, AST, sGPT, ALT; inhibited hepatic 
lipid peroxidation 
(Lin et al., 2003)
Lycii Fructus
枸杞子 (gǒu qǐ zǐ)
Rats LBP 
(300 mg/kg bw)
Decreased AST, ALT; increased antioxidant activity 
(Cheng and Kong, 2011)
Cnidii Fructus 
蛇床子 (shé chuáng zǐ)
Kunming Mice Osthole 
(40 mg/kg bw, p.o.)
Reduced  hepatic oxidative stress; enhanced 
antioxidative enzyme activity; reduced lipid 
accumulation & peroxidation, down-regulation of 
gene expressions of DGAT, HMG-CoA reductase 
and CYP7A mediated by increasing the PPARα 
mRNA expression 
(Sun et al., 2009)
Gentianae Radix 
龍膽 (lóng dǎn)
C57BL/6 mice GM 
(200 mg/kg bw)
Suppressed elevated MDA; restored GSH level; 
enhanced SOD, CAT and GPx activities; blocked 
CYP2E1-mediated free radical scavenging and 
SREBP-1-regulated fatty acid synthesis 
(Lian et al., 2010)
Puerariae Radix 
葛根 (gé gēn) / 
Puerariae Flos 
葛花 (gé huā)
Sprague-Dawley rats Water extracts of PR and PF 
(1.2 g of raw PR or PF/kg 
bw/day)
Normalized antioxidant enzymes, including 
increased Cu/Zn SOD and/or CAT, decreased GPx 
activity 
(Lee et al., 2001)
Sprague-Dawley rats Water extracts of PR 
(1.5 g of raw PR/kg bw/day)
Enhanced lipid metabolism and hepatic antioxidant 
defense system 
(Lee, 2004)
Wistar rats 3 g of raw PR/kg bw/day, 
p.o.
Enhanced  intestinal permeability to improve 
intestinal barrier dysfunction 
(Zhang et al., 2009)
C57BL/6 mice Tectoridin 
(50 mg/kg bw) 
Modulated the disturbance of PPARα pathway and 
ameliorated mitochondrial function 
(Xiong et al., 2010)
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